Publicaciones en colaboración con investigadores/as de Hospital Sagrado Corazón (1)
2019
-
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): An open-label, single-group, multicenter, phase 2 trial
BMC Medicine, Vol. 17, Núm. 1